ACVR1B and myocardial infarction: Our results demonstrated that ALK4 haplodeficiency improved the arrhythmogenic substrate in the ventricular by reversing electrophysiological remodeling and inflammation, and finally attenuated vulnerability to VF/VT in the MI mouse model.